Financials
- Market Capitalization 597.02 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.22
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2808 | TECX Tectonic Therapeutic, Inc. - Common Stock | 30.75 USD | +2.77% | -13.79% | +2.81% | +79.30% | 601.14 M USD | ||
| 2811 | VALN Valneva SE - American Depositary Shares | 6.89 USD | -2.41% | +8.50% | +29.51% | -18.56% | 597.84 M USD | ||
| 2815 | AUTL Autolus Therapeutics plc - American Depositary Shares | 2.24 USD | -2.18% | -3.45% | +14.87% | +51.35% | 596.20 M USD | ||
| 2821 | RGNX REGENXBIO Inc. - Common Stock | 8.94 USD | -2.83% | -5.89% | -20.74% | -33.43% | 590.16 M USD |